Edwin DeJesus

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine”.

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

New England Journal of Medicine(2021)10.1056/nejmoa2105290

N/A

7.5DataRank · unranked

684 citations

Magdalena E. Sobieszczyk, Ian Hirsch, Stephanie Sproule, Merlin L. Robb, Lawrence Corey +40 more

Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial

Nature Medicine(2022)10.1038/s41591-022-01815-1

N/A

2.7DataRank · unranked

143 citations

Kathryn E. Stephenson, Kshitij Wagh, Sabrina C. Tan, Rebecca Zash, Stephen R. Walsh +32 more

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

Nature Medicine(2021)10.1038/s41591-021-01509-0

N/A

2.3DataRank · unranked

104 citations

Boris Jülg, Chen Sabrina Tan, Rebecca Zash, Stephen R. Walsh, Charlotte-Paige Rolle +35 more

Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study

The Lancet HIV(2024)10.1016/s2352-3018(23)00293-x

N/A

1.4DataRank · unranked

45 citations

Susan J. Little, Gordon Crofoot, Paul Cook, Peter Ruane, Dushyantha Jayaweera +12 more

Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa259

N/A

0.466DataRank · unranked

13 citations

Heather J. Ribaudo, Jorge Leon-Cruz, Edgar T. Overton, Markella V. Zanni, Carlos Malvestutto +89 more

The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy

Science Translational Medicine(2021)10.1126/scitranslmed.abg3071

N/A

0DataRank · unranked

78 citations

Cynthia Brinson, Edwin DeJesus, Anthony Mills, Peter Shalit, Susan Guo +19 more

Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study

UNC Libraries(2025)10.17615/jm67-c891

N/A

0DataRank · unranked

0 citations

Anthony Mills, Laurie A. VanderVeen, Paul Cook, Gordon Crofoot, Edwin DeJesus +12 more